Several important drivers have revolutionised drug development processes, and this is predicted to boost the fragment-based drug discovery (FBDD) market to a CAGR of 11.7% between 2023 and 2031. The pharmaceutical industry has given FBDD a lot of attention because of how well it finds very potent lead compounds with a low molecular weight, making chemical synthesis and optimisation much ...
Read More »